IRA WEBB: Open Payments
NPI 1720021447 · BLUEFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 36 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $184 · 2025 $625
Food & beverage: $553Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $226 |
| Teva Pharmaceuticals USA, Inc. | 7 | $165 |
| Vanda Pharmaceuticals Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: VRAYLAR, AUSTEDO XR, COBENFY, FANAPT, TRINTELLIX, REXULTI, INVEGA SUSTENNA, HETLIOZ.
Industry payments across VA — which companies pay providers there.
